Theriva Biologics, Inc. (TOVX)
0.253
0.00 (0.00%)
USD |
NYAM |
Sep 04, 16:00
0.2543
0.00 (0.00%)
Pre-Market: 20:00
Theriva Biologics SG&A Expense (TTM) : 6.919M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.919M |
| March 31, 2026 | 16.07M |
| December 31, 2025 | 15.45M |
| September 30, 2025 | 16.21M |
| June 30, 2025 | 16.62M |
| March 31, 2025 | 6.912M |
| December 31, 2024 | 7.396M |
| September 30, 2024 | 7.723M |
| June 30, 2024 | 5.633M |
| March 31, 2024 | 6.853M |
| December 31, 2023 | 7.121M |
| September 30, 2023 | 9.359M |
| June 30, 2023 | 11.56M |
| March 31, 2023 | 10.42M |
| December 31, 2022 | 9.871M |
| September 30, 2022 | 8.098M |
| June 30, 2022 | 6.985M |
| March 31, 2022 | 6.709M |
| December 31, 2021 | 6.473M |
| September 30, 2021 | 5.14M |
| June 30, 2021 | 5.034M |
| March 31, 2021 | 5.055M |
| December 31, 2020 | 5.029M |
| September 30, 2020 | 5.159M |
| June 30, 2020 | 5.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 4.818M |
| December 31, 2019 | 4.579M |
| September 30, 2019 | 4.498M |
| June 30, 2019 | 4.874M |
| March 31, 2019 | 5.261M |
| December 31, 2018 | 5.727M |
| September 30, 2018 | 6.552M |
| June 30, 2018 | 6.783M |
| March 31, 2018 | 6.996M |
| December 31, 2017 | 7.466M |
| September 30, 2017 | 8.914M |
| June 30, 2017 | 9.304M |
| March 31, 2017 | 9.807M |
| December 31, 2016 | 10.14M |
| September 30, 2016 | 9.203M |
| June 30, 2016 | 8.712M |
| March 31, 2016 | 8.787M |
| December 31, 2015 | 8.074M |
| September 30, 2015 | 7.398M |
| June 30, 2015 | 7.012M |
| March 31, 2015 | 6.604M |
| December 31, 2014 | 6.013M |
| September 30, 2014 | 5.716M |
| June 30, 2014 | 6.388M |
| March 31, 2014 | 5.832M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Yarrow Bioscience, Inc. | 10.57M |
| Nkarta, Inc. | 32.74M |
| Unicycive Therapeutics, Inc. | 23.53M |
| OnKure Therapeutics, Inc. | 15.19M |